What does CUSIP 68235C107 represent in this 13F holders report?

CUSIP 68235C107 is the security identifier for OCX - Oncocyte Corporation - Common Shares, No Par Value used to aggregate holder disclosures.

How many institutions held OCX - Oncocyte Corporation - Common Shares, No Par Value in Q1 2020?

52 institutional investors reported OCX - Oncocyte Corporation - Common Shares, No Par Value for Q1 2020. Use the holders table for investor-level position and value details.

Oncocyte Corporation - Common Shares, No Par Value (OCX)

CUSIP: 68235C107

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Shares, No Par Value
Shares outstanding: 28,495,649
Total 13F shares: 27,664,198
Share change: +1,801,572
Total reported value: $67,748,452
Price per share: $2.45
Number of holders: 52
Value change: +$4,418,527
Number of buys: 28
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 68235C107:

Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BROADWOOD CAPITAL INC	13F	Company	43%	12,274,738	$27,618,000	—	31 Dec 2019	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	20%	5,696,576	$12,817,000	—	31 Dec 2019	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	7.1%	2,035,891	$4,581,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	5.6%	1,587,005	$3,571,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	4.6%	1,301,397	$2,928,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	1.5%	435,208	$979,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	312,765	$703,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.89%	253,054	$569,000	—	31 Dec 2019	13F
P.A.W. CAPITAL CORP	13F	Company	0.88%	250,000	$563,000	—	31 Dec 2019	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.81%	230,300	$518,000	—	31 Dec 2019	13F
Penbrook Management LLC	13F	Company	0.62%	176,878	$398,000	—	31 Dec 2019	13F
BARCLAYS PLC	13F	Company	0.6%	170,733	$384,000	—	31 Dec 2019	13F
Mesirow Financial Investment Management, Inc.	13F	Company	0.57%	162,023	$365,000	—	31 Dec 2019	13F
ETF MANAGERS GROUP, LLC	13F	Company	0.47%	134,213	$286,000	—	31 Dec 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.35%	99,996	$225,000	—	31 Dec 2019	13F
Private Wealth Partners, LLC	13F	Company	0.28%	80,000	$180,000	—	31 Dec 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.24%	68,500	$154,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.23%	64,979	$146,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.21%	58,878	$132,000	—	31 Dec 2019	13F
UBS Group AG	13F	Company	0.19%	55,370	$124,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.19%	54,338	$122,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.19%	54,072	$122,000	—	31 Dec 2019	13F
FEDERATED HERMES, INC.	13F	Company	0.13%	36,027	$81,000	—	31 Dec 2019	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.12%	34,140	$77,000	—	31 Dec 2019	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.12%	33,095	$74,000	—	31 Dec 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.1%	28,265	$64,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.1%	27,972	$63,000	—	31 Dec 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.08%	23,312	$52,000	—	31 Dec 2019	13F
Virtu Financial LLC	13F	Company	0.08%	22,801	$51,000	—	31 Dec 2019	13F
RHUMBLINE ADVISERS	13F	Company	0.06%	17,830	$40,000	—	31 Dec 2019	13F
Williams Jones Wealth Management, LLC.	13F	Company	0.05%	15,000	$34,000	—	31 Dec 2019	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.05%	13,460	$30,000	—	31 Dec 2019	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.05%	12,909	$29,000	—	31 Dec 2019	13F
Arete Wealth Advisors, LLC	13F	Company	0.04%	12,500	$28,000	—	31 Dec 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.04%	10,000	$23,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.03%	7,136	$16,000	—	31 Dec 2019	13F
ROYAL BANK OF CANADA	13F	Company	0.02%	5,339	$12,000	—	31 Dec 2019	13F
CITIGROUP INC	13F	Company	0.02%	4,360	$10,000	—	31 Dec 2019	13F
Legal & General Group Plc	13F	Company	0.02%	4,339	$9,000	—	31 Dec 2019	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.01%	2,963	$6,667	—	31 Dec 2019	13F
SIMPLEX TRADING, LLC	13F	Company	0.01%	3,067	$6,000	—	31 Dec 2019	13F
BANK OF MONTREAL /CAN/	13F	Company	0.01%	2,739	$6,000	—	31 Dec 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	2,461	$6,000	—	31 Dec 2019	13F
Ameritas Investment Partners, Inc.	13F	Company	0.01%	1,896	$4,000	—	31 Dec 2019	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	1,556	$4,000	—	31 Dec 2019	13F
American Portfolios Advisors	13F	Company	0%	1,355	$3,049	—	31 Dec 2019	13F
GROUP ONE TRADING LLC	13F	Company	0%	1,093	$2,000	—	31 Dec 2019	13F
Riggs Asset Managment Co. Inc.	13F	Company	0%	1,000	$2,000	—	31 Dec 2019	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0%	905	$2,000	—	31 Dec 2019	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0%	500	$1,000	—	31 Dec 2019	13F

Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q1 2020

As of 31 Mar 2020, Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,664,198 shares. The largest 10 holders included BROADWOOD CAPITAL INC, PURA VIDA INVESTMENTS, LLC, EMERALD MUTUAL FUND ADVISERS TRUST, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, P.A.W. CAPITAL CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and Phoenix Holdings Ltd.. This page lists 52 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

Q1 2020 holders

Holder diff

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.